Celgene Corporation - CELG - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 12, 2013

Celgene Corporation - SIC # 8731

Ticker	Exchange	SIC #	Website	Latest Ticker
CELG	Nasdaq	8731	http://www.celgene.com/	124.91 +1.43
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Celgene Corporation Final Glance: Biotechnology companies - May 17th, 2013 4:03 pm Final Glance: Biotechnology companies - May 17th, 2013 4:03 pm Celgene Corporation (CELG): Today's Featured Health Care Winner - May 17th, 2013 3:00 pm Midday Glance: Biotechnology companies - May 17th, 2013 11:32 am Midday Glance: Biotechnology companies - May 17th, 2013 11:32 am Bypassing Biotechs and Focusing on the Overlooked Medical Device Space: An Expert Portfolio Manager Discusses His Contrarian Approach to Investing - May 17th, 2013 9:07 am Early Glance: Biotechnology companies - May 17th, 2013 8:25 am Early Glance: Biotechnology companies - May 17th, 2013 8:25 am Today’s 3 Worst Stocks - May 16th, 2013 5:00 pm Stocks Close Lower; Dell Little Changed After Earnings - May 16th, 2013 3:18 pm [video] Stock Pops & Drops - May 16th, 2013 3:00 pm Wall Street Turns Down At The Bell; Celgene Sells Off - May 16th, 2013 2:23 pm Gilead Drug For Leukemia Shows Success In Early Trial - May 16th, 2013 1:29 pm Stocks Flat In Late Trading, But Cisco Lifts Nasdaq - May 16th, 2013 1:26 pm 3 Companies That Put the "Tech" in "Biotech" - May 16th, 2013 12:05 pm Stocks Little Changed; Qihoo, Ocwen Hit New Highs - May 16th, 2013 11:52 am Investing in Health Care Innovation: A Wall Street Transcript Interview with Finny Kuruvilla, Portfolio Manager of the Eventide Gilead Fund - May 16th, 2013 11:23 am AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward - May 16th, 2013 11:04 am Celgene, Gilead lower after new data published at ASCO - May 16th, 2013 9:50 am Myriad Soars Higher on Celeb Clout - May 15th, 2013 12:00 pm View All Current Headlines >>